S Basaria

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. ncbi Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation
    Shehzad Basaria
    Department of Internal Medicine, Boston University School of Medicine, 670 Albany Street, Suite 205, Boston, MA 02118, USA
    J Gerontol A Biol Sci Med Sci 68:153-60. 2013
  2. ncbi Androgen abuse in athletes: detection and consequences
    Shehzad Basaria
    Department of Medicine, Division of Endocrinology and Metabolism, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Clin Endocrinol Metab 95:1533-43. 2010
  3. ncbi Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women
    S Basaria
    Department of Internal Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Endocrinol Invest 32:150-5. 2009
  4. ncbi Preventing skeletal complications in androgen deprived men with prostate cancer: Time for action
    M Braga-Basaria
    Division of Endocrinology, Department of Medicine, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    J Endocrinol Invest 29:467-70. 2006
  5. ncbi Androgens and erythropoiesis: past and present
    S Shahani
    Division of Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, USA
    J Endocrinol Invest 32:704-16. 2009
  6. ncbi Welcoming low testosterone as a cardiovascular risk factor
    M Maggio
    Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Parma, Parma, Italy
    Int J Impot Res 21:261-4. 2009
  7. ncbi Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases
    S Basaria
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 86:5108-17. 2001
  8. ncbi Hypogonadism and androgen replacement therapy in elderly men
    S Basaria
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Med 110:563-72. 2001
  9. ncbi Andropause: to treat or not to treat?
    S Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore 21224, USA
    J Endocrinol Invest 26:693-7. 2003
  10. ncbi Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy
    M Braga-Basaria
    Department of Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    Int J Impot Res 18:494-8. 2006

Collaborators

Detail Information

Publications13

  1. ncbi Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation
    Shehzad Basaria
    Department of Internal Medicine, Boston University School of Medicine, 670 Albany Street, Suite 205, Boston, MA 02118, USA
    J Gerontol A Biol Sci Med Sci 68:153-60. 2013
    ..We evaluated changes in gonadal hormones and markers of inflammation and coagulation to elucidate risk factors associated with cardiovascular events...
  2. ncbi Androgen abuse in athletes: detection and consequences
    Shehzad Basaria
    Department of Medicine, Division of Endocrinology and Metabolism, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Clin Endocrinol Metab 95:1533-43. 2010
    ..With increasing availability of designer androgens, significant efforts are needed by antidoping authorities to develop sensitive methods to detect their use...
  3. ncbi Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women
    S Basaria
    Department of Internal Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Endocrinol Invest 32:150-5. 2009
    ..Isoflavones, a class of plant estrogens, have structural similarities to estradiol. Hence, isoflavones may exert beneficial estrogenic health effects in postmenopausal women with fewer adverse effects...
  4. ncbi Preventing skeletal complications in androgen deprived men with prostate cancer: Time for action
    M Braga-Basaria
    Division of Endocrinology, Department of Medicine, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    J Endocrinol Invest 29:467-70. 2006
  5. ncbi Androgens and erythropoiesis: past and present
    S Shahani
    Division of Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, USA
    J Endocrinol Invest 32:704-16. 2009
    ....
  6. ncbi Welcoming low testosterone as a cardiovascular risk factor
    M Maggio
    Department of Internal Medicine, Division of Endocrinology and Metabolism, University of Parma, Parma, Italy
    Int J Impot Res 21:261-4. 2009
    ..Recent studies have shown low serum testosterone levels to be an independent risk factor of cardiovascular and all-cause mortality. It is time to welcome low serum testosterone levels as a cardiovascular risk factor...
  7. ncbi Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases
    S Basaria
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 86:5108-17. 2001
    ....
  8. ncbi Hypogonadism and androgen replacement therapy in elderly men
    S Basaria
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Med 110:563-72. 2001
    ..This review summarizes the trials of testosterone replacement therapy in elderly men and outlines a diagnostic approach to these patients...
  9. ncbi Andropause: to treat or not to treat?
    S Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore 21224, USA
    J Endocrinol Invest 26:693-7. 2003
  10. ncbi Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy
    M Braga-Basaria
    Department of Medicine, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    Int J Impot Res 18:494-8. 2006
    ..Long-term prospective studies are needed to determine the time of onset of changes in these lipoproteins while on ADT and the influence of these changes on cardiovascular mortality...
  11. ncbi Androgen deprivation therapy for prostate cancer: implications for cardiometabolic clinical care
    L Collins
    Boston University Medical Center, Boston, MA, USA
    J Endocrinol Invest 35:332-9. 2012
    ..This paper serves as a focused review of recent studies examining the metabolic abnormalities and cardiovascular disease related to ADT...
  12. ncbi Andropause: need for concrete guidelines until more evidence becomes available
    S Basaria
    Division of Endocrinology, Department of Medicine, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, MD 21224, USA
    J Endocrinol Invest 28:667-70. 2005
  13. ncbi High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer
    Joshua K Napora
    National Institute of Health, National Institute on Aging, Laboratory of Clinical Investigation, Diabetes Section, Baltimore, Maryland, USA
    J Androl 32:40-8. 2011
    ..We found that high-dose isoflavones over a course of 12 weeks do not improve metabolic or inflammatory parameters in androgen-deprived men...